Literature DB >> 15655742

Comparing interferon- gamma release assay with tuberculin skin test readings at 48-72 hours and 144-168 hours with use of 2 commercial reagents.

David Tat1, Hari Polenakovik, Thomas Herchline.   

Abstract

BACKGROUND: Despite widespread use, the tuberculin skin test (TST) has many limitations, including a requirement for a second visit between 48 and 72 hours. The goal of this study was to determine the reliability of a TST reading between 144 and 168 hours.
METHODS: Tuberculin antigen was applied into both forearms (Aplisol in one arm and Tubersol in the other, from single lots of each product) by the Mantoux method. Blood samples were obtained for interferon- gamma release assay. Subjects were seen at 48-72 hours for the initial (day 2) TST reading and returned at 144-168 hours for a second (day 7) reading.
RESULTS: A total of 116 subjects at increased risk for tuberculosis were studied; 25 (22%) had positive results at day 2 with Tubersol and 27 (23%) had positive results at day 2 with Aplisol. Overall agreement between Tubersol and Aplisol at day 2 was 93% (kappa = 0.80) and at day 7 was 94% (kappa = 0.76). Overall agreement between day 2 and day 7 was 89% for Tubersol and 86% for Aplisol. Discordant results between day 2 and day 7 occurred mostly in persons with a history of bacille Calmette-Guerin vaccination.
CONCLUSIONS: Subjects who fail to present at 48-72 hours for TST reading may still have a reliable TST reading at up to 168 hours. Aplisol and Tubersol reagents produce comparable results when compared with the interferon- gamma release assay.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15655742     DOI: 10.1086/426816

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Changes in tuberculin skin test positivity over 20 years in periurban shantytowns in Lima, Peru.

Authors:  Leonardo Martinez; Alyssa Arman; Nathan Haveman; Ashley Lundgren; Lilia Cabrera; Carlton A Evans; Tom F Pelly; Mayuko Saito; David Callacondo; Richard Oberhelman; Gisela Collazo; Andrés M Carnero; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2013-07-22       Impact factor: 2.345

2.  Predicting success or failure of immunotherapy for cancer: insights from a clinically applicable mathematical model.

Authors:  Charles F Babbs
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

3.  The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis.

Authors:  Edward Raby; Maureen Moyo; Akash Devendra; Joseph Banda; Petra De Haas; Helen Ayles; Peter Godfrey-Faussett
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.